EGIDE (ALGID.PA) Fundamental Analysis & Valuation

EPA:ALGID • FR0000072373

Current stock price

0.98 EUR
+0.02 (+2.08%)
Last:

This ALGID.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. ALGID.PA Profitability Analysis

1.1 Basic Checks

  • ALGID had negative earnings in the past year.
  • In the past year ALGID had a positive cash flow from operations.
  • In multiple years ALGID reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: ALGID reported negative operating cash flow in multiple years.
ALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

1.2 Ratios

  • ALGID's Return On Assets of -14.07% is on the low side compared to the rest of the industry. ALGID is outperformed by 89.09% of its industry peers.
  • ALGID's Return On Equity of -64.06% is on the low side compared to the rest of the industry. ALGID is outperformed by 90.91% of its industry peers.
Industry RankSector Rank
ROA -14.07%
ROE -64.06%
ROIC N/A
ROA(3y)-13.63%
ROA(5y)-7.33%
ROE(3y)-55.38%
ROE(5y)-31.02%
ROIC(3y)N/A
ROIC(5y)N/A
ALGID.PA Yearly ROA, ROE, ROICALGID.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

  • With an excellent Gross Margin value of 62.91%, ALGID belongs to the best of the industry, outperforming 83.64% of the companies in the same industry.
  • ALGID's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for ALGID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
ALGID.PA Yearly Profit, Operating, Gross MarginsALGID.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. ALGID.PA Health Analysis

2.1 Basic Checks

  • ALGID does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ALGID has been increased compared to 1 year ago.
  • ALGID has a better debt/assets ratio than last year.
ALGID.PA Yearly Shares OutstandingALGID.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M
ALGID.PA Yearly Total Debt VS Total AssetsALGID.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • Based on the Altman-Z score of 1.57, we must say that ALGID is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.57, ALGID is not doing good in the industry: 72.73% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of ALGID is 14.31, which is on the high side as it means it would take ALGID, 14.31 years of fcf income to pay off all of its debts.
  • ALGID has a Debt to FCF ratio of 14.31. This is in the lower half of the industry: ALGID underperforms 67.27% of its industry peers.
  • A Debt/Equity ratio of 0.98 indicates that ALGID is somewhat dependend on debt financing.
  • ALGID has a Debt to Equity ratio of 0.98. This is amonst the worse of the industry: ALGID underperforms 83.64% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 14.31
Altman-Z 1.57
ROIC/WACCN/A
WACC7.42%
ALGID.PA Yearly LT Debt VS Equity VS FCFALGID.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • A Current Ratio of 1.57 indicates that ALGID should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.57, ALGID perfoms like the industry average, outperforming 43.64% of the companies in the same industry.
  • ALGID has a Quick Ratio of 1.57. This is a bad value and indicates that ALGID is not financially healthy enough and could expect problems in meeting its short term obligations.
  • ALGID has a worse Quick ratio (0.85) than 69.09% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 0.85
ALGID.PA Yearly Current Assets VS Current LiabilitesALGID.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. ALGID.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 24.41% over the past year.
  • The Revenue has decreased by -8.50% in the past year.
  • Measured over the past years, ALGID shows a very strong growth in Revenue. The Revenue has been growing by 28.35% on average per year.
EPS 1Y (TTM)24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.95%
Revenue 1Y (TTM)-8.5%
Revenue growth 3Y28.35%
Revenue growth 5YN/A
Sales Q2Q%0.97%

3.2 Future

  • The Earnings Per Share is expected to decrease by -25.99% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 0.68% on average over the next years.
EPS Next Y-41.48%
EPS Next 2Y-51.41%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue Next Year22.46%
Revenue Next 2Y-1.63%
Revenue Next 3Y0.68%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALGID.PA Yearly Revenue VS EstimatesALGID.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ALGID.PA Yearly EPS VS EstimatesALGID.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2022 2024 2025 2026 0 -0.1 -0.2 -0.3

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALGID.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • ALGID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALGID. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALGID.PA Price Earnings VS Forward Price EarningsALGID.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40

4.2 Price Multiples

  • ALGID's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 34.56
EV/EBITDA N/A
ALGID.PA Per share dataALGID.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • ALGID's earnings are expected to decrease with -25.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.41%
EPS Next 3Y-25.99%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALGID.PA Dividend Analysis

5.1 Amount

  • No dividends for ALGID!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALGID.PA Fundamentals: All Metrics, Ratios and Statistics

EGIDE

EPA:ALGID (3/13/2026, 7:00:00 PM)

0.98

+0.02 (+2.08%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)10-20
Earnings (Next)04-27
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.22M
Revenue(TTM)30.16M
Net Income(TTM)-3.01M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.64
P/FCF 34.56
P/OCF 22.66
P/B 4.08
P/tB 4.09
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)0.03
FCFY2.89%
OCF(TTM)0.04
OCFY4.41%
SpS1.54
BVpS0.24
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.07%
ROE -64.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.91%
FCFM 1.84%
ROA(3y)-13.63%
ROA(5y)-7.33%
ROE(3y)-55.38%
ROE(5y)-31.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5YN/A
F-Score7
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF 14.31
Debt/EBITDA N/A
Cap/Depr 15.76%
Cap/Sales 0.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.57
Quick Ratio 0.85
Altman-Z 1.57
F-Score7
WACC7.42%
ROIC/WACCN/A
Cap/Depr(3y)34.7%
Cap/Depr(5y)225.04%
Cap/Sales(3y)2%
Cap/Sales(5y)3.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16.95%
EPS Next Y-41.48%
EPS Next 2Y-51.41%
EPS Next 3Y-25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.5%
Revenue growth 3Y28.35%
Revenue growth 5YN/A
Sales Q2Q%0.97%
Revenue Next Year22.46%
Revenue Next 2Y-1.63%
Revenue Next 3Y0.68%
Revenue Next 5YN/A
EBIT growth 1Y42.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y122.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y140.97%
OCF growth 3YN/A
OCF growth 5YN/A

EGIDE / ALGID.PA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

ChartMill assigns a fundamental rating of 2 / 10 to ALGID.PA.


What is the valuation status of EGIDE (ALGID.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to EGIDE (ALGID.PA). This can be considered as Overvalued.


How profitable is EGIDE (ALGID.PA) stock?

EGIDE (ALGID.PA) has a profitability rating of 2 / 10.